Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CysLT1 ELISA Kit (AC3470)
Cat.#: ASET-2059
Specifications
Description Human CysLT1 ELISA Kit allows for the in vitro quantitative determination of human CysLT1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1406 Human Ferritin Light Chain ELISA Kit (AC2817) Quantitative inquiry ASET-2480 Human WFS1 ELISA Kit (AC3891) Quantitative inquiry ASET-1229 Rat Calretinin ELISA Kit (AC2640) Quantitative inquiry ASET-1423 Monkey Leptin ELISA Kit (AC2834) Quantitative inquiry ASET-2501 Human Ferritin Heavy Chain ELISA Kit (AC3912) Quantitative inquiry ASET-2263 Mouse PPAR gamma ELISA Kit (AC3674) Quantitative inquiry ASET-2411 Human Utrophin ELISA Kit (AC3822) Quantitative inquiry ASET-1765 Mouse POMC ELISA Kit (AC3176) Quantitative inquiry ASET-2051 Human Cx30 ELISA Kit (AC3462) Quantitative inquiry ASET-1840 Human Neurexin 1 ELISA Kit (AC3251) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket